Table 3.
Primary outcomes related to diabetes, hypertension and dyslipidemia GPCs, expressed as weighted mean differences between intervention and control groups
| WMD | 95% CI | p | ICC | |
|---|---|---|---|---|
| Annual HbA1c testing (diabetes) | 3.83 | −3.49 to 11.15 | 0.297 | 0.0309 |
| Annual general laboratory testing (hypertension) | 16.22 | −7.35 to 39.80 | 0.172 | 0.0039 |
| Eligible women with CR assessment (dyslipidemia) | 13.58 | 5.00 to 22.16 | 0.003 | 0.0223 |
| Eligible men with CR assessment (dyslipidemia) | 12.91 | 5.24 to 20.57 | 0.001 | 0.0000 |
p-value derived by Student’s t-test
CR cardiovascular risk, CI Confidence Interval, ICC intracluster correlation coefficient, WMD weighted mean difference